Bright light therapy improves cancer-related fatigue in cancer survivors : a randomized controlled trial

DC FieldValueLanguage
dc.contributor.authorJohnson, Jillian A.-
dc.contributor.authorGarland, Sheila N.-
dc.contributor.authorCarlson, Linda E.-
dc.contributor.authorSavard, Josée-
dc.contributor.authorSimpson, John Steven-
dc.contributor.authorAncoli-Israel, Sonia-
dc.contributor.authorCampbell, Tavis S.-
dc.date.accessioned2019-08-13T18:46:24Z-
dc.date.available9999-12-31-
dc.date.issued2017-11-10-
dc.identifier.issn1932-2259fr
dc.identifier.urihttp://hdl.handle.net/20.500.11794/35956-
dc.description.abstractPurpose Cancer-related fatigue (CRF) is a common and distressing symptom that can persist after cancer treatment has concluded. Bright light therapy has shown preliminary efficacy in reducing CRF, but its impact on other psychosocial factors is unclear. The purpose was to examine the impact of a 1-month light therapy intervention on fatigue, mood, and quality of life in cancer survivors with fatigue. Methods This 4-week blinded randomized controlled trial recruited cancer survivors who met diagnostic criteria for CRF. Participants were randomly assigned to receive a light therapy device that produced either bright white light (BWL; intervention) or dim red light (DRL; active control). Participants were instructed to use the device daily for 30 min upon waking for 28 days. The primary outcome, fatigue, was assessed weekly. Secondary outcomes assessed pre- and post-intervention included mood, depressive symptoms, and quality of life. Results A total of 81 participants were randomly assigned to receive BWL (n = 42) or DRL (n = 39). Analyses revealed a group-by-time interaction for fatigue (p = .034), wherein the BWL condition reported a 17% greater reduction in fatigue than those in the DRL condition (between group d = .30). There were also significant improvements over time for both groups on measures of mood, depressive symptoms, and quality of life (p’s < .01). Conclusions BWL was associated with greater improvements in fatigue and both groups displayed improvements on secondary psychosocial outcomes. Implications for cancer survivors These findings, along with previous reports of light therapy for CRF, support the use of this intervention to improve fatigue in cancer survivors.fr
dc.languageengfr
dc.publisherSpringer Naturefr
dc.subjectCancer-related fatiguefr
dc.subjectFatiguefr
dc.subjectLight therapyfr
dc.subjectCancerfr
dc.subjectQuality of lifefr
dc.subjectRandomized controlled trialfr
dc.titleBright light therapy improves cancer-related fatigue in cancer survivors : a randomized controlled trialfr
dc.typeCOAR1_1::Texte::Périodique::Revue::Contribution à un journal::Article::Article de recherchefr
dcterms.bibliographicCitationJournal of Cancer Survivorship, Vol. 12 (2), 206-215 (2018)fr
dc.identifier.doi10.1007/s11764-017-0659-3fr
dc.identifier.pubmed29127575fr
dc.subject.rvmCancer -- Traitement -- Complications et séquellesfr
dc.subject.rvmFatiguefr
dc.subject.rvmPhotothérapiefr
dc.subject.rvmCancéreux -- Santé et hygiènefr
rioxxterms.versionVersion of Recordfr
rioxxterms.version_of_recordhttp://dx.doi.org/10.1007/s11764-017-0659-3fr
rioxxterms.project2012-701425fr
rioxxterms.project.funder_nameCanadian Cancer Society Research Institutefr
bul.rights.periodeEmbargoInfinifr
Collection:Articles publiés dans des revues avec comité de lecture

All documents in CorpusUL are protected by Copyright Act of Canada.